Data from WINConsortium demonstrate the potential of transcriptomics to expand the proportion of Cancer patients eligible for personalized care httpgo.nature.com2DpZyFZÂ PrecisionMedicine clinicaltrials jsoriamd rschilsky MDAndersonNews

Data from @WIN_Consortium demonstrate the potential of #transcriptomics to expand the proportion of #Cancer patients eligible for personalized care | http://go.nature.com/2DpZyFZ #PrecisionMedicine #clinicaltrials @jsoriamd @rschilsky @MDAndersonNews @

13:01 EDT 22 Apr 2019 | Nature Publishing

Data from @WIN_Consortium demonstrate the potential of #transcriptomics to expand the proportion of #Cancer patients eligible for personalized care | http://go.nature.com/2DpZyFZ #PrecisionMedicine #clinicaltrials @jsoriamd @rschilsky @MDAndersonNews @Dr_R_Kurzrock @UCSDHealth pic.twitter.com/2prsvZCrWs

More From BioPortfolio on "Data from @WIN_Consortium demonstrate the potential of #transcriptomics to expand the proportion of #Cancer patients eligible for personalized care | http://go.nature.com/2DpZyFZ #PrecisionMedicine #clinicaltrials @jsoriamd @rschilsky @MDAndersonNews @"